 Connor Clark Lunn Investment Management Ltd. acquired a new stake in shares of Five Prime Therapeutics Inc NASDAQ:FPRX during the fourth quarter, according to its most recent 13F filing with the Securities Exchange Commission. The fund acquired 20,540 shares of the biotechnology companys stock, valued at approximately 94,000. Connor Clark Lunn Investment ... 